Judging by the most shorted stocks traded on the Nasdaq between the August 15 and August 31 settlement dates, those sellers may have been looking for direction.
Judging by the most shorted stocks traded on the Nasdaq between the June 29 and July 13 settlement dates, those sellers were cautious, as their favorites saw shrinking or flat short interest.
The top analyst upgrades, downgrades and other research calls from Wednesday include Advance Auto Parts, Cardinal Health, Dick's Sporting Goods, Home Depot, Lam Research, Snap ad Walmart.
Judging by the most shorted stocks traded on the Nasdaq between the July 31 and August 15 settlement dates, those sellers were focused on one favorite -- Caesars Entertainment.
Judging by the most shorted stocks traded on the Nasdaq between the April 30 and May 15 settlement dates, those sellers were looking for direction, as short interest moves were mixed and mild.
Some analyst calls cover stocks to buy and some cover stocks to sell. Where we often find true hidden gems is in those analyst reports covering small-cap and low-cost stocks.
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Evercore ISI Group has upgraded its outlook for NovoCure to In-Line.
From BioHealth Investor Biotechnology BIONOVO INC [BNVI.OB] +24.42% IOMAI CORPORATION [IOMI] +15.29% GENITOPE CORPORATION [GTOP] +13.17% ARTES MEDICAL, INC. [ARTE] +10.93% MICROMET INC [MITI] +10.04%...
From BioHealth Investor Biotechnology IDERA PHARMACEUTICAL [IDP] +13.53% RENOVIS INC [RNVS] +10.16% COMBINATORX [CRXX] +9.92% IMMUNE RESPONSE NEW [IMRP.OB] +9.86% HANA BIOSCIENCES INC [HNAB] +8.90%...
From BioHealth Investor Biotechnology IDERA PHARMACEUTICAL [IDP] +9.90% BIONOVO INC [BNVI.OB] +9.20% CHELSEA THERAPEUTICS [CHTP] +9.00% CURIS INC [CRIS] +7.58% MICROMET INC [MITI] +5.78% Diagnostic...
The National Venture Capital Association says that VC investments fell slightly more than 50% in the second quarter.The group reports that just 25 venture capital funds raised $1.7 billion in the...
From BioHealth Investor Biotechnology INNOVIVE PHARMACEUTL [IVPH.OB] +23.46% XTL BIOPHARMACEUTICA [XTLB] +22.88% STEMCELLS INC [STEM] +16.92% MEMORY PHARMACEUTICA [MEMY] +16.73% BIONOVO INC [BNVI.OB]...